Schedule 13D ownership disclosure

Ensysce Biosciences, Inc.

Security class unavailable · CUSIP: 293602108

Event date: 2022-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-22-018759
Form type
SC 13D/A
Filer
Ensysce Biosciences, Inc.
CIK
CIK 1716947
Filed
Jul 07, 2022
Reporting period
Jun 30, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub